Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Genome Res ; 19(12): 2317-23, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19819907

ABSTRACT

The Human Microbiome Project (HMP), funded as an initiative of the NIH Roadmap for Biomedical Research (http://nihroadmap.nih.gov), is a multi-component community resource. The goals of the HMP are: (1) to take advantage of new, high-throughput technologies to characterize the human microbiome more fully by studying samples from multiple body sites from each of at least 250 "normal" volunteers; (2) to determine whether there are associations between changes in the microbiome and health/disease by studying several different medical conditions; and (3) to provide both a standardized data resource and new technological approaches to enable such studies to be undertaken broadly in the scientific community. The ethical, legal, and social implications of such research are being systematically studied as well. The ultimate objective of the HMP is to demonstrate that there are opportunities to improve human health through monitoring or manipulation of the human microbiome. The history and implementation of this new program are described here.


Subject(s)
Bacteria , Gastrointestinal Tract/microbiology , Metagenome/genetics , Mouth/microbiology , National Institutes of Health (U.S.) , Skin/microbiology , Vagina/microbiology , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Female , Humans , National Health Programs , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , United States
3.
Health Aff (Millwood) ; 24(4): 991-3, 2005.
Article in English | MEDLINE | ID: mdl-16012139

ABSTRACT

Health care opinion leaders concur that integration of complementary and alternative medicine (CAM) into the U.S. health care system must be based on strong supporting evidence of safety and efficacy. As others have pointed out, integration is under way, despite the lack of reliable, rigorous science supporting the use of most CAM treatments. We contend that optimal integration of CAM is a long-term endeavor--a marathon rather than a sprint. The evidence base does not now support its wholesale assimilation; market forces, although compelling, should not be the primary consideration in integration.


Subject(s)
Complementary Therapies/trends , Delivery of Health Care, Integrated , Biomedical Research/methods , Biomedical Research/standards , Clinical Trials as Topic , Evidence-Based Medicine , Humans , National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division , Safety , Treatment Outcome , United States
SELECTION OF CITATIONS
SEARCH DETAIL